AI assistant
Sending…
Citi Pharma Ltd. — Director's Dealing 2025
May 21, 2025
71782_rns_2025-05-21_befdde5e-af6a-40bd-88ee-c33faddf448b.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| DISCLOSURE OF INTEREST BY RELEVANT PERSONS HOLDING COMPANY'S SHARES UNDER PSX REGULATION 5.6.4. | |||||||
| Details of Transactions | |||||||
| Sr. | Name of Relevant Person(s) with Description |
Form of Share |
Market | Date | Nature | **No. of Share(s) ** | Rate |
| 1 | Nadeem Amjad | CDC | Through CDC | 15-Apr-25 | GIFT OUT | 1,318,268 | 0 |
| 2 | Nadeem Amjad | CDC | Through CDC | 15-Apr-25 | GIFT OUT | 659,134 | 0 |
| 3 | Nadeem Amjad | CDC | Through CDC | 15-Apr-25 | GIFT OUT | 329,567 | 0 |
| 4 | Nadeem Amjad | CDC | Through CDC | 15-Apr-25 | GIFT OUT | 329,567 | 0 |
| 5 | Nadeem Amjad | CDC | Through CDC | 24-Apr-25 | GIFT OUT | 22,850,000 | 0 |
| 6 | Nadeem Amjad | CDC | Through CDC | 8-May-25 | GIFT OUT | 2,700,000 | 0 |
| 7 | Nadeem Amjad | CDC | Through CDC | 8-May-25 | GIFT OUT | 2,700,000 | 0 |
30,886,536
More from Citi Pharma Ltd.
Capital/Financing Update
2026
May 21
M&A Activity
2026
May 6
Interim / Quarterly Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Mar 3
Investor Presentation
2026
Feb 27
Regulatory Filings
2026
Feb 26
Investor Presentation
2026
Feb 20
Interim / Quarterly Report
2026
Feb 18
Interim / Quarterly Report
2026
Feb 13